Abstract
Peptides have been identified in mammalian brain that are considered to be endogenous agonists for the δ (enkephalins) and κ (dynorphins) opiate receptors, but none has been found to have any preference for the µ receptor1–3. Because morphine and other compounds that are clinically useful and open to abuse act primarily at the µ receptor4, it could be important to identify endogenous peptides specific for this site. Here we report the discovery and isolation from brain of such a peptide, endomorphin-1 (Tyr-Pro-Trp-Phe-NH2), which has a high affinity (Ki = 360 pM) and selectivity (4,000- and 15,000-fold preference over the δ and κ receptors) for the µ, receptor. This peptide is more effective than the µ-selective analogue DAMGO in vitroand it produces potent and prolonged analgesia in mice. A second peptide, endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), which differs by one amino acid, was also isolated. The new peptides have the highest specificity and affinity for the µ receptor of any endogenous substance so far described and they maybe natural ligands for this receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Akil, H. et al. Endogenous opioids: Biology and function. Annu. Rev. Neurosci. 7, 223–255 (1984).
Evans, C. J., Hammond, D. L. & Frederickson, R. C. A. in The Opiate Receptors (ed. Pasternak, G. W.) 23–71 (Humana, Clifton, New Jersey, 1988).
Corbett, A. D., Paterson, S. J. & Kosterlitz, H. W. in Opioids I (Handbook of Exp. Pharmacol.) Vol. 104/1 (ed. Herz, A.) 645–679 (Springer, New York, 1993).
Reisine, T. & Pasternak, G. in Goodman and Oilman's The Pharmacological Basis of Therapeutics (eds Hardman, J. G. & Limbird, L. E.) 521–555 (McGraw-Hill, New York, 1996).
Erchegyi, J., Kastin, A. J. & Zadina, J. E. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1). Peptides 13, 623–631 (1992).
Hackler, L., Kastin, A. J., Erchegyi, J. & Zadina, J. E. Isolation of Tyr-W-MIF-1 from bovine hypothalami. Neuropeptides 24, 159–164 (1993).
Erchegyi, J. et al. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1. Peptide Res. 6, 31–38 (1993).
Zadina, J. E., Kastin, A. J., Kenigs, V., Bruno, C. & Hackler, L. Prolonged analgesia after intracer-ebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2). Neurosci. Lett. 155, 220–222 (1993).
Gergen, K. A., Zadina, J. E., Kastin, A. J. & Paul, D. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by α2-adrenoceptors. Eur. J. Pharmacol. 298, 235–239 (1996).
Zadina, J. E., Paul, D., Gergen, K. A., Ge, L.-J., Hackler, L. & Kastin, A. J. Binding of Tyr-W-MIF-1 and related peptides to mu1 and mu2 opiate receptors. Neurosci. Lett. 215, 65–69 (1996).
Gergen, K. A., Zadina, J. E. & Paul, D. Analgesic effects of Tyr-W-MIF-1: A mixed μ2-opioid receptor agonist/μ1-opioid receptor antagonist. Eur. J. Pharmacol. 316, 33–38 (1996).
Zadina, J. E., Kastin, A. J., Ge, L.-J. & Hackler, L. Mu, delta and kappa opiate receptor binding of Tyr-MIF-1 and Tyr-W-MIF-1, its active fragments, and two potent analogs. Life Sci. 55, 461–466 (1994).
Yamazaki, T., Ro, S., Goodman, M., Chung, N. N. & Schiller, P. W. A topochemical approach to explain morphiceptin bioactivity. J. Med. Chem. 36, 708–719 (1993).
Wang, J.-X., Bray, A. M., Dipasquale, A. J., Maeji, N. J. & Geysen, H. M. Systematic study of substance P analogs. I. Evaluation of peptides synthesized by the multipin method for quantitative receptor binding assay. Int. J. Peptide Protein Res. 42, 384–391 (1993).
Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 (1982).
Zadina, J. E., Kastin, A. J., Kersh, D. & Wyatt, A. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum. Life Sci. 51, 869–885 (1992).
Haley, T. J. & McCormick, W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12, 12–15 (1957).
Hylden, J. L. K. & Wilcox, G. L. Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67, 313–316 (1980).
Buscher, H. H. et al. Evidence for analgesic activity of enkephalin in the mouse. Nature 261, 423–425 (1976).
Schiller, P. W., Yam, C. F. & Prosmanne, J. Synthesis, opiate receptor affinity, and conformational parameters of [4-Tryptophan] enkephalin analogues. J. Med. Chem. 21, 1110–1116 (1978).
Lenz, G. R., Evans, S. M., Walters, D. E. & Hopfinger, A. J. Opiates (Academic, Orlando, Florida, 1986).
Brantl, V. et al. Novel opioid peptides derived from hemoglobin: hemorphins. Eur. J. Pharmacol. 125, 309–310 (1986).
Erchegyi, J., Kastin, A. J., Zadina, J. E. & Qiu, X.-D. Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-Thr-Gln (valorphin) with some opiate activity. Int. J. Peptide Protein Res. 39, 477–484 (1992).
Glamsta, E.-L. et al. Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul. Pept. 34, 169–179 (1991).
Brantl, V. Novel opioid peptides derived from human β-casein: Human β-casomorphins. Eur. J. Pharmacol. 106, 213–214 (1984).
Mansour, A., Fox, C. A., Akil, H. & Watson, S. J. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci. 18, 22–29 (1995).
Hamel, E. & Beaudet, A. Electron microscopic autoradiographic localization of opioid receptors in rat neostriatum. Nature 312, 155–157 (1984).
Herkenham, M. in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (eds Fuxe, K. & Agnati, L. F.) 63–87 (Raven, New York, 1991).
Elde, R. et al. in Diversity of Interacting Receptors (eds Abood, L. G. & Lajtha, A.) 390–404 (Acad. Sci., New York, 1995).
Yoburn, B. C., Cohen, A., Umans, J. G., Ling, G. F. & Inturrisi, C. E. The graded and quantal nature of opioid analgesia in the rat tailflick assay. Brain Res. 331, 327–336 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zadina, J., Hackler, L., Ge, LJ. et al. A potent and selective endogenous agonist for the µ-opiate receptor. Nature 386, 499–502 (1997). https://doi.org/10.1038/386499a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/386499a0
This article is cited by
-
The P2Y1 receptor in the colonic myenteric plexus of rats and its correlation with opioid-induced constipation
BMC Gastroenterology (2024)
-
The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism
Current Diabetes Reports (2022)
-
Peripheral Administration of an Opioid Peptide Analog Ameliorates Morphine-Produced Hyperalgesia in a Spared Nerve Injury Model
International Journal of Peptide Research and Therapeutics (2022)
-
Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak
Cellular and Molecular Neurobiology (2021)
-
Structure–activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity
Amino Acids (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.